EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 351 filers reported holding EXELIXIS INC in Q2 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $253,304 | -42.4% | 15,792 | -43.7% | 0.01% | -38.5% |
| Q3 2022 | $440,000 | +71.2% | 28,060 | +119.2% | 0.01% | +116.7% |
| Q4 2020 | $257,000 | -49.2% | 12,800 | -55.4% | 0.01% | +100.0% |
| Q4 2019 | $506,000 | +40.9% | 28,711 | +90.1% | 0.00% | 0.0% |
| Q1 2019 | $359,000 | -10.0% | 15,100 | -6.8% | 0.00% | -96.1% |
| Q2 2017 | $399,000 | -11.9% | 16,197 | -22.5% | 0.08% | -14.6% |
| Q1 2017 | $453,000 | +84.9% | 20,896 | +27.1% | 0.09% | +8.5% |
| Q4 2016 | $245,000 | -67.5% | 16,445 | -72.1% | 0.08% | -68.1% |
| Q3 2016 | $754,000 | +111.2% | 58,941 | +29.0% | 0.26% | +32.5% |
| Q2 2016 | $357,000 | +839.5% | 45,691 | +211.8% | 0.19% | +397.4% |
| Q1 2015 | $38,000 | +26.7% | 14,652 | -30.7% | 0.04% | +56.0% |
| Q4 2014 | $30,000 | – | 21,143 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |